NANOVIBRONIX INC (NAOV) Stock Price, Forecast & Analysis
NASDAQ:NAOV • US63008J8844
NAOV Key Statistics, Chart & Performance
The current stock price of NAOV is 4.02 USD. In the past month the price decreased by -16.08%. In the past year, price decreased by -99.41%.
NAOV Technical Analysis
NAOV Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NAOV. Both the profitability and financial health of NAOV have multiple concerns.
NAOV Financial Highlights
Over the last trailing twelve months NAOV reported a non-GAAP Earnings per Share(EPS) of -83.93. The EPS increased by 39.01% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -10.54% | ||
| ROE | -13.4% | ||
| Debt/Equity | 0.05 |
NAOV Forecast & Estimates
NAOV Ownership
NAOV Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.55 | 195.936B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.27 | 172.536B | ||
| SYK | STRYKER CORP | 24.42 | 139.985B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.78 | 110.826B | ||
| IDXX | IDEXX LABORATORIES INC | 42.26 | 50.254B | ||
| BDX | BECTON DICKINSON AND CO | 11.26 | 50.113B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.39 | 44.027B | ||
| RMD | RESMED INC | 20.83 | 36.792B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.25 | 36.615B | ||
| DXCM | DEXCOM INC | 27.89 | 27.309B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NAOV
Company Profile
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The company is headquartered in Tyler, Texas and currently employs 15 full-time employees. The company went IPO on 2015-04-24. The firm focuses on two distinct technology platforms: Acoustic-based therapeutic technologies, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters. The ENvue Navigation Platform, which is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract. ENvue provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure.
Company Info
NANOVIBRONIX INC
969 Pruitt Piace
Tyler TEXAS 10523 US
CEO: Brian Murphy
Employees: 31
Phone: 19142333004
NANOVIBRONIX INC / NAOV FAQ
What does NANOVIBRONIX INC do?
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The company is headquartered in Tyler, Texas and currently employs 15 full-time employees. The company went IPO on 2015-04-24. The firm focuses on two distinct technology platforms: Acoustic-based therapeutic technologies, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters. The ENvue Navigation Platform, which is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract. ENvue provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure.
Can you provide the latest stock price for NANOVIBRONIX INC?
The current stock price of NAOV is 4.02 USD. The price decreased by -6.73% in the last trading session.
What is the dividend status of NANOVIBRONIX INC?
NAOV does not pay a dividend.
How is the ChartMill rating for NANOVIBRONIX INC?
NAOV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What sector and industry does NANOVIBRONIX INC belong to?
NANOVIBRONIX INC (NAOV) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Can you provide the number of employees for NANOVIBRONIX INC?
NANOVIBRONIX INC (NAOV) currently has 31 employees.